Sign in
RAPT Stock Price, Chart, Stats & News
RAPT Therapeutics, Inc.
Save
959.26M
Market cap
–
Current P/E
–
Forward P/E
RAPT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -63.74% |
ROE | -61.81% |
D/E | 0.02x |
Interest coverage ratio | – |
RAPT valuation
P/E | – |
P/S | – |
P/B | 10.29x |
P/CF | -18.06x |
P/FCF | -11.07x |
P/OCF | -18.06x |
PEG | -0.67x |
EV multiple | -9.21x |
About
RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical firm specializing in immunology. The company is dedicated to discovering, developing, and commercializing innovative oral small molecule therapies. These treatments are aimed at addressing critical unmet medical needs for patients battling oncology and inflammatory diseases.
Similar securities
Based on sector and market capitalization
Report issue